Fortress Biotech Inc (FBIO) Upgraded to Hold by ValuEngine

Fortress Biotech Inc (FBIO) Upgraded to Hold by ValuEngine


FBIO has been the topic of a number of other reports. Zacks Investment Research raised shares of Fortress Biotech from a "sell" rating to a "buy" rating and set a $4.50 price objective on the stock in a research note on Monday, May 15th.



from Biotech News